Connection

Alessandro Rambaldi to Prospective Studies

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Prospective Studies.
Alessandro Rambaldi
Connection Strength
0.068
Prospective Studies
  1. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
    View in: PubMed
    Score: 0.038
  2. Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant. 2018 09; 53(9):1193-1197.
    View in: PubMed
    Score: 0.008
  3. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. Clin Infect Dis. 2017 Nov 13; 65(11):1884-1896.
    View in: PubMed
    Score: 0.007
  4. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. Leuk Res. 2017 12; 63:34-40.
    View in: PubMed
    Score: 0.007
  5. Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen. Biol Blood Marrow Transplant. 2017 Jul; 23(7):1102-1109.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.